Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche’s vision loss therapy faricimab extends time between treatments by up to four months

pharmatimesFebruary 20, 2021

Tag: Roche , faricimab , nAMD , DME

PharmaSources Customer Service